While some of the biggest names available did not find new homes on Tuesday, a whole lot of relievers are wearing new duds. So let’s get down to business.

The New York Yankees acquired pitcher Keynan Middleton for pitcher Juan Carela

With all the relief trades made by the White Sox, Middleton must have felt a bit like the last kid taken in gym class this weekend. This has been the year he’s put it all together, thanks to a much-improved changeup that has become his money pitch, resulting in hitters no longer simply waiting around to crush his fairly ordinary fastball. He’s a free agent after the season and certainly not meriting a qualifying offer, so the Sox were right to get what they could.

I’m mostly confused about this from the Yankees’ standpoint. He does upgrade the bullpen, which ranks below average in our depth charts for the first time I can recall. But unless they really like him and hope to lock him up to a contract before he hits free agency, I’m not sure what the Bombers get out of tinkering with their bullpen a little when the far more pressing problems in the lineup and rotation went unaddressed. As for Carela, he’s been solid in High-A ball this year, but he really ought to be as a repeater. Just how much of a lottery ticket he is won’t be better known until we see if he can continue his improvement against a better quality of hitter. Read the rest of this entry »

About 12 hours after Bo Bichette left Monday night’s game with a right knee injury, the Blue Jays found his possible replacement, acquiring shortstop Paul DeJong and cash considerations from the Cardinals on Tuesday afternoon for minor league reliever Matt Svanson.

DeJong being relevant again might make you think that you’ve warped back to pre-2020 days, but hang on before you load up on masks and toilet paper; he’s actually had a nice little 2023 season. I don’t think anyone would argue with me if I said the Cardinals were having a season with a stunning lack of pleasant surprises, but DeJong’s year has been one of those rarities. While a triple-slash of .233/.297/.412 won’t get you to many All-Star Games, it’s a much prettier line than his .196/.280/.351 collapse from 2020 to ’22, reaching a nadir with a ’22 season in which DeJong needed a telescope just to see the Mendoza line. He still plays solid defense at shortstop, and his bat has rebounded enough that there’s once again a significant role for him on a major league roster. The only reason he was even in St. Louis this year was the six-year contract he signed before the 2018 season.

The #BlueJays are sending minor-league reliever Matt Svanson, 24, in return for Paul DeJong and cash considerations. DeJong, who's in the final year of a six-year, $26 million contract, earns $9M this year with a $12.5M option or $2M buyout in 2024.

— Bob Nightengale (@BNightengale) August 1, 2023

While this piece has the “2023 trade deadline tag,” that’s actually kind of a lie; this is a regular ol’ injury replacement trade that just happened to coincide with the deadline. The full extent of Bichette’s injury probably won’t be known before the trade market closes up shop for the fall, so the Jays had to act quickly unless they wanted to try to replace him in-house. And while they had options in the organization, all of them had at least one seriously concerning issue. Santiago Espinal is more an emergency shortstop than a starter, and Cavan Biggio only has two professional innings at short. And neither is providing enough offense to make you want to take that defensive risk. In the minors, Addison Barger has suffered through elbow problems this season and isn’t a natural shortstop either, and Orelvis Martinez just debuted at Triple-A. Ernie Clement turning into a weird plate discipline deity is interesting, but more for a bad team in search of an upside play, not a team in a tight, crowded pennant race that needs some certainty.

DeJong’s options are now a little more complicated. At $12.5 million and $15 million, I imagine the Cardinals would have declined them as they did with Kolten Wong after a solid 2020 season. He has a $2 million buyout for 2024, and there may be a scenario in which the Jays pick it up if Bichette’s injury turns out to be fairly serious one. Is $10.5 million (since $2 million is baked into the cake either way) minus whatever the Cardinals are sending with him not worth it for them to keep DeJong as the starting shortstop for an undetermined part of next season before making him a utility infielder?

There was no reason to expect the Cardinals to get a haul of prospects for DeJong. Svanson is having a bit of a breakout season in the minors as a reliever, but you can’t ignore the fact that it’s as a 24-year-old in High-A ball. My colleague Eric Longenhagen has his two-seamer at 92–94 mph and his slider at 84, and that he would be an honorable mention in the Jays prospect list but would not make the main rankings. ZiPS turns Svanson’s 1.23 ERA/2.55 FIP into a 4.30 ERA translation with the Cardinals in 2023 because, well, 24-year-old in High-A ball. But if he advances quickly — and he will need to in order to have any kind of career in the majors — he could show up at the back of the big league bullpen.

Toronto would much prefer that Bichette’s knee is a minor issue that resolves quickly, but they’ve rightly formulated a solid Plan B here. There’s literally no time like the present.

*****BREAKING NEWS UPDATE EMERGENCY SIREN JAZZ HANDS*****

There’s no serious damage to Bichette’s knee, though it’s not determined whether or not he will need to head onto the IL. At the very least, we might see Bichette play more DH as they work him back into the lineup, whenever it is, and DeJong still remains a quality Plan B in the case of a setback. Bichette’s injury not being a serious one does reduce the chance that the Blue Jays will pick up one of DeJong’s options.

As everyone has seen by now, an MRI showed there is no structural damage in Bo Bichette’s right knee, per #BlueJays manager John Schneider, who described it as best case scenarios. Bichette isn’t in the lineup today but he’s day to day. Still determining if an IL stint is needed

— Kaitlyn McGrath (@kaitlyncmcgrath) August 1, 2023

*****END COMMUNIQUE*****

The Cubs made it clear that they’re buyers on Monday afternoon, acquiring third baseman Jeimer Candelario from the Nationals for shortstop Kevin Made and pitcher DJ Herz.

What a difference a week makes! After losing the opener of a four-game series to the Cardinals just over a week ago, the Cubs stood at 45–51, and it seemed more likely that they would be sellers than buyers come deadline time. An eight-game winning streak later, off the backs of the hated Cardinals and the moribund White Sox, changed that calculus; even a Sunday loss to break the streak wasn’t enough to banish the idea that the NL Central was there for the taking. After all, four games in the standings isn’t that wide a chasm, and with the fourth-best run differential in the National League, there’s at least one legitimate reason to think the Cubs have deserved better than their .500 record this year. The Pirates have faded, the Cardinals wouldn’t be trading off talent if even they thought they had a miracle in them, and neither of the Reds or Brewers are likely to take big steps forward. Read the rest of this entry »

One of the biggest names on the trade market found a new home on Saturday evening as the Texas Rangers picked up pitcher Max Scherzer from the New York Mets in return for shortstop prospect Luisangel Acuña, per Andy Martino. Scherzer’s contract runs through 2024 at a hefty $43.33 million per season, with the Mets covering a little more than $35 million of his remaining deal. Per Jeff Passan, Scherzer won’t exercise his player opt-out and will remain with the Rangers through the end of his contract. Read the rest of this entry »

The White Sox sent closer Kendall Graveman to the Astros for catching prospect Korey Lee on Friday afternoon. Graveman, signed by the White Sox to a three-year contract days before the 2021–22 lockout started, put up a 3.30 ERA and a 4.00 FIP in 110 appearances with Chicago. This caps off a busy end-of-week flurry for the Sox: Graveman is now the fifth pitcher they’ve traded in 24 hours, after Lucas Giolito, Reynaldo López, Lance Lynn, and Joe Kelly.

Graveman’s peripheral numbers have slid this season as his strikeout and walk rates have continued to deteriorate, and the six homers he’s allowed this season almost match the eight he surrendered in 2021 and ’22 combined, but I’m slightly less concerned about this than I would be in many similar situations. For one, his plate discipline-against numbers don’t support his problems in these departments. Batters are making contact against Graveman less often than any time in his career (ignoring his five-appearance debut season), and his first-strike percentage, a useful leading indicator of walk rate, is better than ever.

Some of the changes seem to be from conscious approach decisions. Graveman started throwing his four-seamer a lot more often in 2022 and has continued that this year but is now almost exclusively throwing it center-high. The result has been a lot more loft on these pitches. In fact, basically all of Graveman’s pitches, including his sinker, have been hit about 10 degrees higher than last year. It’s been enough to transform him from a reasonably strong groundballer in recent years to a pitcher allowing more fly balls than average. On the negative side, his slider has lost some bite, with its break closer to league-average than at his peak, leading to a lower whiff rate (35%) than in 2022 (43%) or ’21 (44%). ZiPS sees him with a 3.59 FIP for the rest of 2023 in Houston and a 3.72 mark in 2024. Read the rest of this entry »

With less than a week to go until the trade deadline, things have been relatively quiet on the transaction front, possibly due to the uncertainty surrounding Shohei Ohtani’s availability. But now that an Ohtani trade is off the table, I think we can expect things to really start moving in the next day or so. That makes this the perfect time for one of my favorite/most dreaded pieces of the year, in which I kick things off with some trade imagineering that hopefully doesn’t result in too many people being mad at me. Not all of these deals would necessarily be accepted if they were offered as-is — teams value players differently, after all — nor am I reporting on actual trades that are in the works. But I tried to make sure that each of these deals was plausible and actually met the needs of the teams in question. Let’s get to it!

The Philadelphia Phillies acquire 1B Paul Goldschmidt from the St. Louis Cardinals for OF Johan Rojas, SS Hao-Yu Lee, and OF Carlos De La Cruz

Right now, the Phillies are hoping to get Rhys Hoskins, who is a free agent at the end of the season, back for a playoff run. But rather than pin their postseason dreams on a guy coming off a significant injury, why not simply get a plug-and-play first baseman who is signed through 2024? If Hoskins turns out to be healthy for the playoffs, the Phillies will have an extra pinch-hitter ready for situational duty. But if they trade for Goldschmidt, it would solidify first base while also allowing them to put Bryce Harper back at DH most games. That would leave Kyle Schwarber and the heavily slumping Nick Castellanos to fight for playing time once Cristian Pache returns from his elbow injury (assuming he picks up where he left off). The Phillies are ninth in the NL in runs scored and with a fairly set lineup, there just aren’t a lot of places to add significant run production. Goldschmidt is about as good as you can do at the deadline this year. Read the rest of this entry »

12:03

Dan Szymborski: Sorry I was slightly late, was finishing up my yearly trade dictator piece.

12:03

Dan Szymborski: I suspect we always were headed towards a less than smooth CBA after this one expires, but way too soon to tell if it results in missed games.

12:04

Dan Szymborski: On a fundamental level, the things that players are really unhappy about really haven’t changed all that much.

12:04

Dan Szymborski: Luxury tax threshold still grow slower than inflation and slower than MLB’s revenue growth.

Read the rest of this entry »

The Braves made two minor moves on Monday to fill out their bullpen headcount, acquiring right-handed reliever Pierce Johnson from the Rockies and lefty reliever Taylor Hearn from the Rangers. Heading to Colorado are righty relief pitcher Victor Vodnik, our no. 13 Braves prospect a few months ago, and minor league starter Tanner Gordon. The return for Hearn is unknown as of press time, but it’s unlikely the Rangers will be getting a prospect of much significance.

The Rockies have traded RHP Pierce Johnson to the Braves for a pair of minor leaguers, per source.

— Mark Feinsand (@Feinsand) July 24, 2023

If these turn out to be the biggest trades made over the last week of July, it would be a mighty disappointing deadline, but the Braves get what they wanted here. Their bullpen hasn’t exactly struggled this season — it’s second in FIP, WAR, and ERA — but adding a bit of depth while they still can has a lot of appeal to it. Through graduations and trades in recent years, the top of their farm system is kind of shallow at the moment, so internal reinforcements would be a bit trickier. Not helping matters is that they currently have five relievers on injured lists, four of them on the 60-day IL, and basically have no additional relievers on the 40-man roster left to call up in a pinch without shoving a starting pitcher in there.

Johnson is probably the safer bet of the two pickups, and I don’t necessarily mean to damn him with faint praise considering the season he’s had so far. Even in a Coors Field environment, an ERA of six is not what you like to see, and even the FIP in the mid-fours hardly screams “pitcher you’re going to use in high-leverage situations.” Johnson took over the closer role when Daniel Bard had to step away from baseball temporarily earlier this season. He only blew a couple of saves before losing the gig last month, but his walk rate this season — never his strength — led to a lot of adventures like you’d see from Fernando Rodney in a down year. Johnson’s saving grace, and almost certainly the reason the Braves valued him, is that he misses bats and throws hard; if carefully managed, he can be an asset to the ‘pen. Read the rest of this entry »

The full midseason run of the ZiPS projections have been completed, and while the standings updates are always a lot of fun, they tend to move in a similar direction to our FanGraphs standings, so they’re usually not the most shocking. What I find the most interesting are the player projections — not even the numbers for the rest of the season (the in-season model is simpler, but improvements in the full model are naturally going to be incremental), but the ones that look toward 2024 and beyond.

After looking at the hitter gainers and decliners and then the pitcher gainers, we’re wrapping this up with the list of the pitchers with the largest declines in projected 2024 WAR since my original projections to dig a little into what changed for each player. Sometimes it’s performance, sometimes it’s health, sometimes it’s a change in position. Let’s jump straight into the names, since I assume everyone reading this knows that ZiPS isn’t a cheeseburger or a hoodie.

One note: For this list, I looked only at the pitchers who have played in the majors whose sole decline isn’t because of injuries; otherwise, the list would simply be “dudes having Tommy John surgery” and fringe Double-A prospects who hit the wall suddenly. I doubt you need any help from a projection system to know why Carlos Rodón’s projection is worse now. Read the rest of this entry »

12:01

Dan Szymborski: https://getyarn.io/yarn-clip/e86a78a7-713d-4d6b-8a93-4fad86923866

12:02

Dan Szymborski: Martinez is back to pretty much where his projection was – ZiPS was already aggressive with him

12:03

Dan Szymborski: His projection really fell off in the earl going, but he’s been much better last couple months

12:06

Dan Szymborski: Outside of the big names, it gets unimpressive quickly!

Read the rest of this entry »